Pathway Financial Advisers’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,647
Closed -$87.4K 185
2025
Q3
$87.4K Buy
+1,647
New +$89.4K 0.03% 194
2025
Q1
Sell
-1,588
Closed -$57.6K 188
2024
Q4
$57.6K Sell
1,588
-55,606
-97% -$2.01M 0.02% 222
2024
Q3
$1.56K Buy
57,194
+55,652
+3,609% +$1.99M ﹤0.01% 362
2024
Q2
$47.7K Buy
1,542
+27
+2% +$820 0.02% 231
2024
Q1
$46.2K Sell
1,515
-133
-8% -$4K 0.02% 234
2023
Q4
$48.3K Buy
1,648
+22
+1% +$669 0.02% 226
2023
Q3
$51K Buy
+1,626
New +$53.6K 0.02% 222
2023
Q1
$21.9K Buy
624
+8
+1% +$302 0.01% 299
2022
Q4
$24.6K Buy
+616
New +$24.2K 0.01% 306

Other funds holding BTI

Pathway Financial Advisers's BTI Position: Q4 2025 in Review

Pathway Financial Advisers sold out of British American Tobacco (BTI) in Q4 2025, closing a stake of 1,647 shares — an estimated $87.4K sold.

Pathway Financial Advisers first reported a position in BTI in Q4 2022 and held it in 9 quarters. The position peaked at $87.4K in Q3 2025. 823 funds tracked by Wall St. Rank hold BTI as of Q4 2025.

  • Pathway Financial Advisers reported no remaining British American Tobacco position as of Q4 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 1,647 British American Tobacco shares in Q4 2025, an estimated $87.4K.
  • Pathway Financial Advisers first reported a position in British American Tobacco in Q4 2022 and held it in 9 quarters.
  • Pathway Financial Advisers's British American Tobacco position peaked at $87.4K in Q3 2025.
  • 823 funds tracked by Wall St. Rank held British American Tobacco as of Q4 2025.

Based on Pathway Financial Advisers's 13F filing for Q4 2025, filed 6 Feb 2026.